Results 131 to 140 of about 381,426 (191)

NKG2D Ligands in Pediatric Cancer [PDF]

Biology of Blood and Marrow Transplantation, 2013
Gupta, Neha Das, Wang, Chong, Holladay, Martha, Rooney, Barbara, Leung, Wing   +4 more
openaire   +1 more source

Epigenetic modulation of NKG2D ligands enhances NKG2D-CAR T cell efficacy in neuroblastoma. [PDF]

J Transl Med
Navarro-Zapata A, De Santisteban MO, Regojo-Zapata RM, Ibáñez-Navarro M, Clares-Villa L, de la Hoz M, Romero A, Mestre-Durán C, Al-Akioui Sanz K, Bareke H, Naharro S, Minguillón J, Pertíñez L, Riestra N, Masot M, Martín-Cortázar C, Aguirre-Portolés C, Ferreras C, Mañas A, Pérez-Martínez A, Casanova LF.   +20 more
europepmc   +1 more source

Longitudinal Dynamics of Soluble NKG2D Ligands in Mild and Moderate Coronavirus Disease-2019. [PDF]

Yonago Acta Med
Nagamizu K, Nishikawa Y, Takata M, Yamaguchi K, Hashimoto Y, Morishita S, Shofiudin MA, Okada K, Kitaura T, Nakamoto M, Yamasaki A, Chikumi H.   +11 more
europepmc   +1 more source

The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases. [PDF]

Front Mol Neurosci
Pogoda-Wesołowska A, Sługocka N, Synowiec A, Brodaczewska K, Mejer-Zahorowski M, Ziękiewicz M, Szypowski W, Szymański P, Stępień A.   +8 more
europepmc   +1 more source

Sesamin induces cell cycle arrest and upregulation of NKG2D ligands in MG‑63 cells and increases susceptibility to NK cell cytotoxicity. [PDF]

Exp Ther Med
Chou SC, Kuo CY, Ko HW, Huang PT, Liu CH, Wang LS, Liang YJ.   +6 more
europepmc   +1 more source

Staphylococcus aureus induces cell-surface expression of immune stimulatory NKG2D ligands on human monocytes. [PDF]

J Biol Chem, 2020
Mellergaard M, Høgh RI, Lund A, Aldana BI, Guérillot R, Møller SH, Hayes AS, Panagiotopoulou N, Frimand Z, Jepsen SD, Hansen CHF, Andresen L, Larsen AR, Peleg AY, Stinear TP, Howden BP, Waagepetersen HS, Frees D, Skov S.   +18 more
europepmc   +1 more source

Analysis of immune-modulatory effects of NKG2D ligands on T cells.

, 2007
The predominantly on NK cells and CD8+ T cells expressed activating receptor NKG2D binds several structurally diverse ligands, which are poorly expressed on “normal” resting cells, but can become upregulated on tumors and otherwise stressed ...
Kriegeskorte, A.K.
core  

Impaired immune reconstitution in HIV infection: the role of CD4⁺ T-cell-associated NKG2D ligands, CD4⁺ T-cell subsets imbalance, and immune function deficiency. [PDF]

Front Immunol
Xu Q, Zhang Q, Xu P, Zhang T, Wu H, Zhang X, Moog C, Su B.   +7 more
europepmc   +1 more source

Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands. [PDF]

Int J Mol Sci
Díaz-Tejedor A, Rodríguez-Ubreva J, Ciudad L, Lorenzo-Mohamed M, González-Rodríguez M, Castellanos B, Sotolongo-Ravelo J, San-Segundo L, Corchete LA, González-Méndez L, Martín-Sánchez M, Mateos MV, Ocio EM, Garayoa M, Paíno T.   +14 more
europepmc   +1 more source

Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells. [PDF]

J Immunother Cancer
Baugh R, Khalique H, Page E, Lei-Rossmann J, Wan PK, Johanssen T, Ebner D, Ansorge O, Seymour LW.   +8 more
europepmc   +1 more source